218 related articles for article (PubMed ID: 7671999)
1. Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture.
Brent PJ; Pang GT
Eur J Pharmacol; 1995 May; 278(2):151-60. PubMed ID: 7671999
[TBL] [Abstract][Full Text] [Related]
2. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract][Full Text] [Related]
3. Correlation between potentiation of neurogenic twitch contraction and benzomorphan sigma receptor binding potency in the mouse vas deferens.
Matsuno K; Senda T; Mita S
Eur J Pharmacol; 1993 Feb; 231(3):451-7. PubMed ID: 8449236
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of sigma ligand-activated receptor subtypes that modulate NMDA-evoked [3H]-noradrenaline release in rat hippocampal slices.
Monnet FP; de Costa BR; Bowen WD
Br J Pharmacol; 1996 Sep; 119(1):65-72. PubMed ID: 8872358
[TBL] [Abstract][Full Text] [Related]
5. Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex.
Matsuno K; Matsunaga K; Senda T; Mita S
J Pharmacol Exp Ther; 1993 May; 265(2):851-9. PubMed ID: 8496830
[TBL] [Abstract][Full Text] [Related]
6. Effects of sigma ligands on mouse cerebellar cyclic guanosine monophosphate (cGMP) levels in vivo: further evidence for a functional modulation of N-methyl-D-aspartate (NMDA) receptor complex-mediated events by sigma ligands.
Rao TS; Mick SJ; Cler JA; Emmett MR; Dilworth VM; Contreras PC; Gray NM; Wood PL; Iyengar S
Brain Res; 1991 Oct; 561(1):43-50. PubMed ID: 1686745
[TBL] [Abstract][Full Text] [Related]
7. [Possible role of sigma-receptors in the regulation of cough reflex, gastrointestinal and retinal function].
Kamei J
Nihon Yakurigaku Zasshi; 1999 Jul; 114(1):35-41. PubMed ID: 10562963
[TBL] [Abstract][Full Text] [Related]
8. Characterization of specific (+)-[3H]N-allylnormetazocine and [3H]1,3-di(2-tolyl)guanidine binding sites in porcine gastric fundic mucosa.
Harada Y; Hara H; Sukamoto T
J Pharmacol Exp Ther; 1994 Jun; 269(3):905-10. PubMed ID: 8014877
[TBL] [Abstract][Full Text] [Related]
9. Characterization of specific binding sites for [3H]-1,3-di-o-tolyl-guanidine (DTG) in the rat glioma cell line C6-BU-1.
Georg A; Friedl A
Glia; 1992; 6(4):258-63. PubMed ID: 1464457
[TBL] [Abstract][Full Text] [Related]
10. Modulation by sigma ligands of intracellular free Ca++ mobilization by N-methyl-D-aspartate in primary culture of rat frontal cortical neurons.
Hayashi T; Kagaya A; Takebayashi M; Shimizu M; Uchitomi Y; Motohashi N; Yamawaki S
J Pharmacol Exp Ther; 1995 Oct; 275(1):207-14. PubMed ID: 7562551
[TBL] [Abstract][Full Text] [Related]
11. Involvement of sigma-receptors in the increase in contraction of mouse vas deferens induced by exogenous ATP.
Matsuno K; Kobayashi T; Mita S
J Pharm Pharmacol; 1996 Jan; 48(1):96-9. PubMed ID: 8722504
[TBL] [Abstract][Full Text] [Related]
12. [3H]1,3-di(2-tolyl) guanidine binds to a sigma 2 receptor on Jurkat cell membranes, but sigma compounds fail to influence immunomodulatory events in human peripheral blood lymphocytes.
DeHaven-Hudkins DL; Daubert JD; Sawutz DG; Tiberio L; Baine Y
Immunopharmacology; 1996 Oct; 35(1):27-39. PubMed ID: 8913792
[TBL] [Abstract][Full Text] [Related]
13. Sigma ligands indirectly modulate the NMDA receptor-ion channel complex on intact neuronal cells via sigma 1 site.
Yamamoto H; Yamamoto T; Sagi N; Klenerová V; Goji K; Kawai N; Baba A; Takamori E; Moroji T
J Neurosci; 1995 Jan; 15(1 Pt 2):731-6. PubMed ID: 7529831
[TBL] [Abstract][Full Text] [Related]
14. Interaction of 1,3-di(2-[5-3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations.
Dumont M; Lemaire S
Eur J Pharmacol; 1991 Dec; 209(3):245-8. PubMed ID: 1665796
[TBL] [Abstract][Full Text] [Related]
15. Cocaine-sensitive sigma-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma cells.
Ramamoorthy JD; Ramamoorthy S; Mahesh VB; Leibach FH; Ganapathy V
Endocrinology; 1995 Mar; 136(3):924-32. PubMed ID: 7867601
[TBL] [Abstract][Full Text] [Related]
16. Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB; Bruce A; Feinstein G; Orringer J; Williams W; Bowen WD
Eur J Pharmacol; 1994 Jun; 268(1):9-18. PubMed ID: 7925616
[TBL] [Abstract][Full Text] [Related]
17. Evidence against an involvement of the haloperidol-sensitive sigma recognition site in the discriminative stimulus properties of (+)-N-allylnormetazocine ((+)-SKF 10,047).
Singh L; Wong EH; Kesingland AC; Tricklebank MD
Br J Pharmacol; 1990 Jan; 99(1):145-51. PubMed ID: 2158832
[TBL] [Abstract][Full Text] [Related]
18. Kappa opioid receptor agonists inhibit sigma-1 (sigma 1) receptor binding in guinea-pig brain, liver and spleen: autoradiographical evidence.
Brent PJ
Brain Res; 1996 Jul; 725(2):155-65. PubMed ID: 8836521
[TBL] [Abstract][Full Text] [Related]
19. Multiple vascular effects of sigma and PCP ligands: inhibition of amine uptake and contractile responses.
Massamiri T; Duckles SP
J Pharmacol Exp Ther; 1990 Apr; 253(1):124-9. PubMed ID: 2158542
[TBL] [Abstract][Full Text] [Related]
20. Effect of short-term and long-term treatments with sigma ligands on the N-methyl-D-aspartate response in the CA3 region of the rat dorsal hippocampus.
Bergeron R; de Montigny C; Debonnel G
Br J Pharmacol; 1997 Apr; 120(7):1351-9. PubMed ID: 9105712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
